Omnicell Inc is a healthcare technology company that specializes in streamlining medication management and supply chain solutions for pharmacies and healthcare facilities. The company develops automated systems and software that enhance the efficiency of medication dispensing, inventory management, and patient safety. By offering a comprehensive suite of products, including automated dispensing cabinets, central pharmacy automation, and cloud-based analytics, Omnicell aims to improve the operational workflows of healthcare providers, reduce medication errors, and ultimately enhance patient care. Their innovative solutions are designed to meet the evolving needs of the healthcare industry, supporting successful medication therapies and optimizing pharmacy operations. Read More
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Dan Mandoli, a seasoned healthcare executive with more than 30 years of leadership across pharmacy operations and specialty pharmacy services, has joined the Company as Senior Vice President and General Manager, Specialty Pharmacy Services.
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a...
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 on Tuesday, June 9, 2026, at 3:20 PM EDT.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Hims & Hers Health (NYSE:HIMS) and its peer...
Omnicell’s 23% return over the past six months has outpaced the S&P 500 by 13%, and its stock price has climbed to $43.73 per share. This was partly due to i...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
Omnicell’s first quarter was marked by strong execution and operational improvements, leading to results that exceeded Wall Street’s expectations. Management...
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the BofA Securities 2026 Healthcare Conference on Tuesday, May 12, 2026, at 8:40 a.m. PDT.
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Rick Couldry has joined the Company as Senior Vice President, Chief Pharmacy and Clinical Officer.
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 14.9% year on year to $30...
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 14.9% year on year to $3...
